BCYC Jun 2024 22.500 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

1.7400

0.0000

(0.00%)

At close: 03:26PM EDT

Loading interactive chart...

Zacks
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
We have narrowed our search to five small-cap biotech stocks with strong potential for the rest of 2024. These are: ARQT, BCYC, CSTL, PRME, LXRX.
Zacks
Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year?
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, England & BOSTON, June 03, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in June: